SEC Form 4 · accession 0001144204-18-032470
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Myron Z Holubiak
Director
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $42.09 | May 30, 2018 | A | 7,500 | A | — | May 30, 2028 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The shares of common stock underlying the option will vest upon the earlier of (i) May 30, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders.
Remarks
Exhibit List: Exhibit 24.1 - Power of Attorney